Anirban P Mitra

Title: Anirban P Mitra: Innovator in Urothelial Carcinoma Prognosis

Introduction

Anirban P Mitra is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer research, particularly in the prognosis of urinary bladder cancer. His innovative work has the potential to improve patient outcomes through advanced diagnostic methods.

Latest Patents

Anirban P Mitra holds a patent for a "Prognostic panel for urinary bladder cancer." This invention relates to methods of prognosing urothelial carcinoma. In one embodiment, the invention provides a method of prognosing urothelial carcinoma by determining expression levels of JUN, MAP2K6, STAT3, and/or ICAM1. Additionally, the invention includes a single prognostic panel made up of eight gene markers, as well as another panel consisting of eleven gene markers. This patent represents a significant advancement in the early detection and treatment of bladder cancer.

Career Highlights

Anirban P Mitra is affiliated with the University of Southern California, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a commitment to improving cancer prognosis and treatment methodologies.

Collaborations

Anirban collaborates with Richard J Cote, a fellow researcher, to further enhance the impact of their work in cancer research. Their combined expertise contributes to the development of effective diagnostic tools.

Conclusion

Anirban P Mitra's contributions to the field of urothelial carcinoma prognosis exemplify the importance of innovation in medical research. His patent and ongoing work at the University of Southern California highlight his dedication to improving cancer diagnostics and patient care.